SuperworthMedpace shares outstanding MEDP
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 28.6M
- On a year earlier
- −2.0%
- fewer shares
Medpace had 28.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.0% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 29M | −9% |
| FY2024 | 31.9M | +0% |
| FY2023 | 31.8M | −2% |
| FY2022 | 32.4M | −14% |
| FY2021 | 37.9M | +0% |
| FY2020 | 37.7M | −0% |
| FY2019 | 37.8M | +1% |
| FY2018 | 37.3M | −1% |
| FY2017 | 37.8M | −6% |
| FY2016 | 40.3M | +28% |
| FY2015 | 31.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 28.6M | −2% | |
| Q1 FY26 | 29M | −7% | |
| Q4 FY25 | 29M | −9% | |
| Q3 FY25 | 28.8M | −10% | |
| Q2 FY25 | 29.1M | −9% | |
| Q1 FY25 | 31.2M | −3% | |
| Q4 FY24 | 31.9M | +0% | |
| Q3 FY24 | 32.1M | +1% | |
| Q2 FY24 | 32.1M | +2% | |
| Q1 FY24 | 32M | −0% | |
| Q4 FY23 | 31.8M | −2% | |
| Q3 FY23 | 31.8M | −2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Medpace
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.